Alset
NASDAQ:AEIAlset Inc., together with its subsidiaries, engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments. The Real Estate segment develops property projects and participates in third-party property development projects; and owns, operates, and manages real estate development projects with a focus on land subdivision developments and house rental projects. The Digital Transformation Technology segment provides consulting, implementation, and development services with various technologies, including blockchain, e-commerce, social media, and payment solutions. Its technology platform focuses on business-to-business solutions, such as communications and workflow, instant messaging, international calling, social media, e-commerce and payment systems, and direct marketing solutions. The Biohealth segment engages in developing, researching, testing, manufacturing, licensing, and distributing biohealth products and services. The Other Business Activities segment offers corporate strategy and business development, asset management, corporate restructuring, and leveraged buy-out expertise services. It also operates cafes which is located in Singapore and South Korea. The company was formerly known as Alset EHome International Inc. and changed its name to Alset Inc. in October 2022. Alset Inc. was incorporated in 2018 and is headquartered in Bethesda, Maryland.
Comstock Holding Companies
NASDAQ:CHCIComstock Holding Companies, Inc. operates as a real estate asset manager of mixed-use and transit-oriented properties in the Washington, D.C. region. The company acquires, develops, operates, and sells residential, commercial, and mixed-use properties. It provides a suite of asset management, property management, development and construction management, and other real estate services to its asset-owning clients composes primarily of institutional real estate investors, high net worth family offices, and governmental bodies with surplus real estate holdings. The company was formerly known as Comstock Homebuilding Companies, Inc. and changed its name to Comstock Holding Companies, Inc. in June 2012. Comstock Holding Companies, Inc. was founded in 1985 and is headquartered in Reston, Virginia.
Leju
NYSE:LEJULeju Holdings Limited, through its subsidiaries, provides online to offline (O2O) real estate services in the People's Republic of China. It offers real estate e-commerce, online advertising, and online listing services through its online platform, and various mobile applications. The company also operates various real estate and home furnishing Websites of SINA Corporation (SINA). Its O2O services for new residential properties include selling discount coupons; and facilitating online property viewing, physical property visits, marketing events, and pre-sale customer support, as well as provides information platform to individual brokers. In addition, the company sells advertising primarily on the SINA new residential properties and home furnishing websites; and acts as an advertising agent for the SINA home page and non-real estate Websites with respect to advertising sold to real estate developers and home furnishing suppliers. Further, it offers fee-based online property listing services to real estate agents; and services to individual property sellers. The company was incorporated in 2013 and is headquartered in Beijing, the People's Republic of China.
Rafael
NYSE:RFLRafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.